EA200802324A1 - Новая форма введения рацекадотрила - Google Patents

Новая форма введения рацекадотрила

Info

Publication number
EA200802324A1
EA200802324A1 EA200802324A EA200802324A EA200802324A1 EA 200802324 A1 EA200802324 A1 EA 200802324A1 EA 200802324 A EA200802324 A EA 200802324A EA 200802324 A EA200802324 A EA 200802324A EA 200802324 A1 EA200802324 A1 EA 200802324A1
Authority
EA
Eurasian Patent Office
Prior art keywords
racecadotrial
introduction
new form
new
racecadotril
Prior art date
Application number
EA200802324A
Other languages
English (en)
Other versions
EA014707B1 (ru
Inventor
Жан-Шарль Шварц
Жанн-Мари Лёкомт
Original Assignee
Биопроже
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37552919&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200802324(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Биопроже filed Critical Биопроже
Publication of EA200802324A1 publication Critical patent/EA200802324A1/ru
Publication of EA014707B1 publication Critical patent/EA014707B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к новой лекарственной форме рацекадотрила в виде таблеток, способу их изготовления и их использованию для лечения диареи.
EA200802324A 2006-05-15 2007-05-14 Новая форма введения рацекадотрила EA014707B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0604302A FR2900823B1 (fr) 2006-05-15 2006-05-15 Nouvelle forme d'administration du racecadotril.
PCT/FR2007/000814 WO2007132091A1 (fr) 2006-05-15 2007-05-14 Nouvelle forme d'administration du racecadotril

Publications (2)

Publication Number Publication Date
EA200802324A1 true EA200802324A1 (ru) 2009-04-28
EA014707B1 EA014707B1 (ru) 2011-02-28

Family

ID=37552919

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802324A EA014707B1 (ru) 2006-05-15 2007-05-14 Новая форма введения рацекадотрила

Country Status (28)

Country Link
US (1) US8318203B2 (ru)
EP (1) EP2018158B1 (ru)
KR (1) KR101432116B1 (ru)
CN (2) CN101442990A (ru)
AP (1) AP2627A (ru)
AU (1) AU2007251471B2 (ru)
BR (1) BRPI0710405B8 (ru)
CA (1) CA2652023C (ru)
CY (1) CY1114190T1 (ru)
DK (1) DK2018158T3 (ru)
EA (1) EA014707B1 (ru)
EC (1) ECSP088889A (ru)
ES (1) ES2421929T3 (ru)
FR (1) FR2900823B1 (ru)
HR (1) HRP20130624T1 (ru)
IL (1) IL195270A (ru)
MA (1) MA30466B1 (ru)
MX (1) MX2008014554A (ru)
NO (1) NO342977B1 (ru)
NZ (1) NZ573424A (ru)
PL (1) PL2018158T3 (ru)
PT (1) PT2018158E (ru)
RS (1) RS52912B (ru)
SI (1) SI2018158T1 (ru)
TN (1) TNSN08428A1 (ru)
UA (1) UA98299C2 (ru)
WO (1) WO2007132091A1 (ru)
ZA (1) ZA200809721B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2632441C2 (ru) * 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
CN102133186B (zh) * 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
CN105848643A (zh) * 2013-12-23 2016-08-10 强生消费者公司 消旋卡多曲组合物
EP2918268A1 (en) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
EP2949318A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising racecadotril
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
JP6851973B2 (ja) * 2015-02-09 2021-03-31 リボファーム・エスエーＲｉｖｏｐｈａｒｍ Ｓａ ラセカドトリルの医薬製剤
CN106822907B (zh) * 2016-12-29 2021-02-09 山东达因海洋生物制药股份有限公司 一种含消旋卡多曲的双相释放制剂及其制备方法
WO2018163195A1 (en) * 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
CN1635884A (zh) * 2000-06-23 2005-07-06 生物计划公司 包含外消旋卡朵曲的干粉制剂
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
EP1563848A1 (en) * 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
EP2135602A1 (en) * 2004-08-13 2009-12-23 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2632441C2 (ru) * 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила

Also Published As

Publication number Publication date
AP2627A (en) 2013-03-26
CN101442990A (zh) 2009-05-27
IL195270A0 (en) 2009-08-03
US20090186084A1 (en) 2009-07-23
RS52912B (en) 2014-02-28
UA98299C2 (ru) 2012-05-10
ZA200809721B (en) 2009-06-24
AU2007251471A1 (en) 2007-11-22
CY1114190T1 (el) 2016-08-31
EP2018158A1 (fr) 2009-01-28
NO20084826L (no) 2008-12-12
HRP20130624T1 (en) 2013-08-31
BRPI0710405A2 (pt) 2011-08-09
BRPI0710405B8 (pt) 2021-05-25
AP2008004686A0 (en) 2008-12-31
US8318203B2 (en) 2012-11-27
ECSP088889A (es) 2009-01-30
KR20090017593A (ko) 2009-02-18
KR101432116B1 (ko) 2014-08-21
FR2900823A1 (fr) 2007-11-16
NZ573424A (en) 2012-03-30
IL195270A (en) 2016-08-31
CN103961328A (zh) 2014-08-06
PT2018158E (pt) 2013-07-24
MA30466B1 (fr) 2009-06-01
EP2018158B1 (fr) 2013-04-24
ES2421929T3 (es) 2013-09-06
CA2652023C (fr) 2016-06-28
FR2900823B1 (fr) 2009-02-13
DK2018158T3 (da) 2013-07-22
AU2007251471B2 (en) 2012-03-15
EA014707B1 (ru) 2011-02-28
SI2018158T1 (sl) 2013-09-30
BRPI0710405B1 (pt) 2019-01-08
WO2007132091A1 (fr) 2007-11-22
PL2018158T3 (pl) 2013-09-30
NO342977B1 (no) 2018-09-17
TNSN08428A1 (fr) 2010-04-14
CA2652023A1 (fr) 2007-11-22
MX2008014554A (es) 2008-11-27

Similar Documents

Publication Publication Date Title
EA200802324A1 (ru) Новая форма введения рацекадотрила
EA201300465A1 (ru) Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
EA201070544A1 (ru) Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
EA201101192A1 (ru) Фармацевтическая композиция, включающая производные глюкопиранозилдифенилметана, фармацевтическая дозированная форма, содержащая указанные производные, способ их получения и применения для улучшения гликемического контроля у пациентов
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
FR2883179B1 (fr) Comprime enrobe
NO20081636L (no) FAP - inhibitorer
EA200700851A1 (ru) Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения
MX2011002966A (es) Formas de dosificacion farmaceutica que comprenden poli (e-caprolactona).
CL2010001474A1 (es) Compuestos derivados de tiofeno o tiazol sustituidos, inhibidores de pi3k; composicion farmaceutica; utiles en el tratamiento del cancer, inflamacion y en el tratamiento de trastornos cardiovasculares.
EA201170832A1 (ru) Пуриновые соединения
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
EA201170425A1 (ru) Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
MX2009012920A (es) Compuestos heptaciclicos y usos farmaceuticos de los mismos para la prevencion y tratamiento de diabetes y sindrome metabolico.
CY1116216T1 (el) Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου
EA201190312A1 (ru) Замещенные пиперидины

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM